Poland· PL-100317685
Vokanamet
A metformin and canagliflozin product containing canagliflozinum + metformini hydrochloridum, registered in Poland by Janssen-Cilag International N.V.. The same ATC class is registered in 11 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Metformin and canagliflozin is registered in 11 of 19 countries.
Countries holding a registration under ATC A10BD16 (metformin and canagliflozin), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 7 of them publish a price we can compare per daily dose
Metformin and canagliflozin · ATC A10BD16
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Netherlands
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
URPL (Poland)- Active substance
- Canagliflozinum + Metformini hydrochloridum
- Manufacturer
- Janssen-Cilag International N.V.
- Country
- Poland (PL)
- ATC code
- A10BD16
- ATC class
- Metformin and canagliflozin
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 3
- gtin05909991142186
- gtin05909991142193
- gtin05909991142209
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
2 interactions on record for metformin and canagliflozin.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Metformin and canagliflozin · interactions on record
2 records
2 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame medicine, other countries
Metformin and canagliflozin in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaVOKANAMETJanssen-Cilag International N.V., Beerse
- United StatesINVOKAMETJanssen Pharmaceuticals, Inc.
- SwitzerlandVokanamet 150 mg / 1000 mg, FilmtablettenJanssen-Cilag AG
- FinlandVokanametJanssen-Cilag International NV
- IcelandVokanametJanssen-Cilag International NV*
- NetherlandsVokanamet 150 mg/1.000 mg filmomhulde tablettenJanssen-Cilag International NV
- SwedenVokanamet 150 mg/1000 mg Filmdragerad tablettJanssen-Cilag International NV
- SpainVOKANAMET 150 MG/1000 MG COMPRIMIDOS RECUBIERTOS CON PELICULAJanssen-Cilag International N.V
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Vokanamet
- Liechtenstein · Vokanamet
- Norway · Vokanamet
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/368fe67d-f1f3-49f4-8709-e9bb1a7f1d45 GET /v1/drugs/368fe67d-f1f3-49f4-8709-e9bb1a7f1d45?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki powlekane",
"source": "urpl",
"strength": "50 mg + 1000 mg",
"packaging": "05909991142186 ¦ Rp ¦ EU/1/14/918/004 ¦ 92065\n20 tabl.\n05909991142193 ¦ Rp ¦ EU/1/14/918/005 ¦ 92066\n60 tabl.\n05909991142209 ¦ Rp ¦ EU/1/14/918/006 ¦ 92067\n180 tabl.",
"substance": "Canagliflozinum 50 mg + Metformini hydrochloridum 1000 mg",
"common_name": "Canagliflozinum + Metformini hydrochloridum",
"pl_product_id": "100317685",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about metformin and canagliflozin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.